-
132021.04
Accent Therapeutics Announces $63 Million Series B Financing to Advance Novel, Precision Cancer TherAccent Therapeutics Announces $63 Million Series B Financing to Advance Novel, Precision Cancer Therapies Targeting RNA-Modifying Proteins | Business Wire
2021-04-13
MORE -
132021.04
Silverback Therapeutics Raises $78.5 Million in Oversubscribed Series B FinancingSilverback Therapeutics Raises $78.5 Million in Oversubscribed Series B Financing | Business Wire
2021-04-13
MORE -
132021.04
Akrevia Therapeutics Rebrands as Xilio Therapeutics and Announces $100.5 Million Series B FinancingAkrevia Therapeutics Rebrands as Xilio Therapeutics and Announces $100.5 Million Series B Financing | Business Wire
2021-04-13
MORE -
132021.04
Harpoon Therapeutics Announces Closing of $70M Series C FinancingHarpoon Therapeutics Announces Closing of $70M Series C Financing | Business Wire
2021-04-13
MORE -
132021.04
NextCure Raises $93 Million in Series B FinancingNextCure Raises $93 Million in Series B Financing | Business Wire
2021-04-13
MORE -
132021.04
Surrozen Secures $50M in Series B FinancingSurrozen Secures $50M in Series B Financing | FinSMEs
2021-04-13
MORE -
132021.04
에이치엘비 RCPS, 운용사 한번 더 '러브콜'더벨 - 국내 최고 자본시장(Capital Markets) 미디어 (thebell.co.kr)
2021-04-13
MORE -
132021.04
Morphic Therapeutic Raises $80M in Series B FinancingMorphic Therapeutic Raises $80M in Series B Financing | FinSMEs
2021-04-13
MORE -
132021.04
Fulcrum Therapeutics Announces $80 Million Series B FinancingFulcrum Therapeutics Announces $80 Million Series B Financing | Business Wire
2021-04-13
MORE -
132021.04
Constellation Pharmaceuticals Raises $100M FinancingConstellation Pharmaceuticals Raises $100M Financing | FinSMEs
2021-04-13
MORE